169 related articles for article (PubMed ID: 23888188)
1. HLX in AML: novel prognostic and therapeutic target.
Pandolfi A; Steidl U
Oncotarget; 2012 Oct; 3(10):1059-60. PubMed ID: 23888188
[No Abstract] [Full Text] [Related]
2. A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways.
Piragyte I; Clapes T; Polyzou A; Klein Geltink RI; Lefkopoulos S; Yin N; Cauchy P; Curtis JD; Klaeylé L; Langa X; Beckmann CCA; Wlodarski MW; Müller P; Van Essen D; Rambold A; Kapp FG; Mione M; Buescher JM; Pearce EL; Polyzos A; Trompouki E
Nat Commun; 2018 Aug; 9(1):3090. PubMed ID: 30082823
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the role of aberrantly expressed MNX1 (HLXB9) in infant acute myeloid leukemia.
Schwaller J
Haematologica; 2019 Jan; 104(1):1-3. PubMed ID: 30598492
[No Abstract] [Full Text] [Related]
4. A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy.
Raymond A; Liu B; Liang H; Wei C; Guindani M; Lu Y; Liang S; St John LS; Molldrem J; Nagarajan L
Oncotarget; 2014 Dec; 5(24):12675-93. PubMed ID: 25544748
[TBL] [Abstract][Full Text] [Related]
5. H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia.
Kawahara M; Pandolfi A; Bartholdy B; Barreyro L; Will B; Roth M; Okoye-Okafor UC; Todorova TI; Figueroa ME; Melnick A; Mitsiades CS; Steidl U
Cancer Cell; 2012 Aug; 22(2):194-208. PubMed ID: 22897850
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR‑135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression.
Xu H; Wen Q
Mol Med Rep; 2018 Jul; 18(1):1134-1140. PubMed ID: 29845297
[TBL] [Abstract][Full Text] [Related]
7. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
8. HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells.
Bei L; Huang W; Wang H; Shah C; Horvath E; Eklund E
J Biol Chem; 2011 May; 286(21):19047-64. PubMed ID: 21471217
[TBL] [Abstract][Full Text] [Related]
9. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
[TBL] [Abstract][Full Text] [Related]
10. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
Kikushige Y; Miyamoto T
Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
[TBL] [Abstract][Full Text] [Related]
11. GFI1 as a novel prognostic and therapeutic factor for AML/MDS.
Hönes JM; Botezatu L; Helness A; Vadnais C; Vassen L; Robert F; Hergenhan SM; Thivakaran A; Schütte J; Al-Matary YS; Lams RF; Fraszscak J; Makishima H; Radivoyevitch T; Przychodzen B; da Conceição Castro SV; Görgens A; Giebel B; Klein-Hitpass L; Lennartz K; Heuser M; Thiede C; Ehninger G; Dührsen U; Maciejewski JP; Möröy T; Khandanpour C
Leukemia; 2016 Jun; 30(6):1237-45. PubMed ID: 26847026
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of Hlx in immature Th cells induces IFN-gamma expression.
Zheng WP; Zhao Q; Zhao X; Li B; Hubank M; Schatz DG; Flavell RA
J Immunol; 2004 Jan; 172(1):114-22. PubMed ID: 14688316
[TBL] [Abstract][Full Text] [Related]
13. CTCF boundary remodels chromatin domain and drives aberrant
Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
[No Abstract] [Full Text] [Related]
14. Homeodomain protein HLX is expressed primarily in cytotrophoblast cell types in the early pregnancy human placenta.
Rajaraman G; Murthi P; Quinn L; Brennecke SP; Kalionis B
Reprod Fertil Dev; 2008; 20(3):357-67. PubMed ID: 18402755
[TBL] [Abstract][Full Text] [Related]
15. Targeting LSD1 for acute myeloid leukemia (AML) treatment.
Zhang S; Liu M; Yao Y; Yu B; Liu H
Pharmacol Res; 2021 Feb; 164():105335. PubMed ID: 33285227
[TBL] [Abstract][Full Text] [Related]
16. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia.
Tian C; Yu Y; Jia Y; Zhu L; Zhang Y
Ann Hematol; 2015 Sep; 94(9):1477-83. PubMed ID: 26092281
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer.
Rouhi A; Fröhling S
Oncotarget; 2013 Feb; 4(2):174-5. PubMed ID: 23563447
[No Abstract] [Full Text] [Related]
18. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
19. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors.
Esposito MT; Zhao L; Fung TK; Rane JK; Wilson A; Martin N; Gil J; Leung AY; Ashworth A; So CW
Nat Med; 2015 Dec; 21(12):1481-90. PubMed ID: 26594843
[TBL] [Abstract][Full Text] [Related]
20. Widespread over-expression of the non-clustered homeobox gene HLX in acute myeloid leukemia.
Fröhling S
Haematologica; 2012 Oct; 97(10):1453. PubMed ID: 23053668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
